Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Zachary Yuschock, PharmD Candidate
Advertisement
Articles by Zachary Yuschock, PharmD Candidate
Advertisement
Latest Updated Articles
- Boehringer Ingelheim Pharmaceuticals' Pradaxa
Published: December 13th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Experts Highlight Key Sessions and Emerging Topics from The Menopause Society 2025 Annual Meeting
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
5
